Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 382

1.

Insights into Parkinson's disease from computational models of the basal ganglia.

Humphries MD, Obeso JA, Dreyer JK.

J Neurol Neurosurg Psychiatry. 2018 Apr 17. pii: jnnp-2017-315922. doi: 10.1136/jnnp-2017-315922. [Epub ahead of print] Review.

PMID:
29666208
2.

DBS for Parkinson's disease with behavioural disturbances.

Antonini A, Obeso JA.

Lancet Neurol. 2018 Mar;17(3):195-197. doi: 10.1016/S1474-4422(18)30044-9. No abstract available.

PMID:
29452675
3.

Editor's tribute: Dr. Robert Burke.

Obeso JA.

Mov Disord. 2018 Feb;33(2):185. doi: 10.1002/mds.27332. No abstract available.

PMID:
29427343
4.

2018 message from the editor in chief-Movement Disorders journal at cruise speed.

Obeso JA.

Mov Disord. 2018 Jan;33(1):1-2. doi: 10.1002/mds.27289. No abstract available.

PMID:
29330922
5.

Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.

Rodriguez-Rojas R, Carballo-Barreda M, Alvarez L, Guridi J, Pavon N, Garcia-Maeso I, Macías R, Rodriguez-Oroz MC, Obeso JA.

J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241. doi: 10.1136/jnnp-2017-316241. [Epub ahead of print]

PMID:
29222224
6.

Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias.

Picconi B, Hernández LF, Obeso JA, Calabresi P.

Mov Disord. 2017 Dec 8. doi: 10.1002/mds.27261. [Epub ahead of print] Review.

PMID:
29219207
7.

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA.

Lancet Neurol. 2018 Jan;17(1):54-63. doi: 10.1016/S1474-4422(17)30403-9. Epub 2017 Dec 5.

PMID:
29203153
8.

Parkinson's Disease Is Not Simply a Prion Disorder.

Surmeier DJ, Obeso JA, Halliday GM.

J Neurosci. 2017 Oct 11;37(41):9799-9807. doi: 10.1523/JNEUROSCI.1787-16.2017. Review.

9.

Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

Blesa J, Trigo-Damas I, Dileone M, Del Rey NL, Hernandez LF, Obeso JA.

Exp Neurol. 2017 Dec;298(Pt B):148-161. doi: 10.1016/j.expneurol.2017.10.002. Epub 2017 Oct 4. Review.

PMID:
28987461
10.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

PMID:
28887905
11.

Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson's disease.

Quiroga-Varela A, Aguilar E, Iglesias E, Obeso JA, Marin C.

Neuroscience. 2017 Oct 11;361:144-156. doi: 10.1016/j.neuroscience.2017.08.017. Epub 2017 Aug 18.

PMID:
28823819
12.

What would Dr. James Parkinson think today? The 21st Annual Congress of the International Parkinson's disease and movement disorders society.

Obeso JA, Trenkwalder C.

Mov Disord. 2017 Jul;32(7):951-954. doi: 10.1002/mds.27108. No abstract available.

PMID:
28712120
13.

Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes.

Obeso I, Casabona E, Rodríguez-Rojas R, Bringas ML, Macías R, Pavón N, Obeso JA, Jahanshahi M.

Cortex. 2017 Sep;94:39-48. doi: 10.1016/j.cortex.2017.06.006. Epub 2017 Jun 27.

PMID:
28711816
14.

Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.

Gasca-Salas C, García-Lorenzo D, Garcia-Garcia D, Clavero P, Obeso JA, Lehericy S, Rodríguez-Oroz MC.

Brain Imaging Behav. 2017 Jul 14. doi: 10.1007/s11682-017-9751-6. [Epub ahead of print]

PMID:
28710667
15.

Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.

Dileone M, Carrasco-López MC, Segundo-Rodriguez JC, Mordillo-Mateos L, López-Ariztegui N, Alonso-Frech F, Catalan-Alonso MJ, Obeso JA, Oliviero A, Foffani G.

Sci Rep. 2017 Jun 28;7(1):4329. doi: 10.1038/s41598-017-04254-y.

16.

To lesion or not to lesion: That was the question (Reply to "stereotactic ablative surgery does not just mean 'adding another lesion'").

Obeso JA, Martinez-Fernandez R, Del Álamo M, Krack P.

Mov Disord. 2017 Jul;32(7):1113-1114. doi: 10.1002/mds.27066. Epub 2017 Jun 14. No abstract available.

PMID:
28612948
17.

Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys.

Pifl C, Reither H, Del Rey NL, Cavada C, Obeso JA, Blesa J.

Front Neuroanat. 2017 May 29;11:46. doi: 10.3389/fnana.2017.00046. eCollection 2017.

18.

In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.

Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, Bessede A, Obeso JA, Matute C, Ichas F, Bezard E.

Neurobiol Dis. 2017 Jul;103:101-112. doi: 10.1016/j.nbd.2017.04.011. Epub 2017 Apr 11.

PMID:
28411117
19.

The use of nonhuman primate models to understand processes in Parkinson's disease.

Blesa J, Trigo-Damas I, Del Rey NL, Obeso JA.

J Neural Transm (Vienna). 2018 Mar;125(3):325-335. doi: 10.1007/s00702-017-1715-x. Epub 2017 Mar 29. Review.

PMID:
28357564
20.

Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.

F Hernández L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R.

Mov Disord. 2017 Apr;32(4):530-537. doi: 10.1002/mds.26947. Epub 2017 Mar 3.

PMID:
28256089
21.

Current applications and limitations of surgical treatments for movement disorders.

Krack P, Martinez-Fernandez R, Del Alamo M, Obeso JA.

Mov Disord. 2017 Jan;32(1):36-52. doi: 10.1002/mds.26890. Review.

PMID:
28124435
22.

Editors' Note: The 200th Anniversary of the Shaking Palsy.

Obeso JA, Jon Stoessl A, Stamelou M.

Mov Disord. 2017 Jan;32(1):1. doi: 10.1002/mds.26904. No abstract available.

PMID:
28124430
23.

What Would Dr. James Parkinson Think Today? I. The Role of Functional Neurosurgery for Parkinson's Disease.

Hariz M, Obeso JA.

Mov Disord. 2017 Jan;32(1):2-4. doi: 10.1002/mds.26911. No abstract available.

PMID:
28124429
24.

Selective neuronal vulnerability in Parkinson disease.

Surmeier DJ, Obeso JA, Halliday GM.

Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178. Review.

25.

Coexisting Parkinson's and Wilson's Disease: Chance or Connection?

Gasca-Salas C, Alonso A, González-Redondo R, Obeso JA.

Can J Neurol Sci. 2017 Mar;44(2):215-218. doi: 10.1017/cjn.2016.327. Epub 2016 Nov 10. No abstract available.

PMID:
27831460
26.

Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.

Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC.

J Neurosurg. 2016 Nov;125(5):1068-1079. Epub 2016 Feb 5.

PMID:
26848922
27.

Computer keyboard interaction as an indicator of early Parkinson's disease.

Giancardo L, Sánchez-Ferro A, Arroyo-Gallego T, Butterworth I, Mendoza CS, Montero P, Matarazzo M, Obeso JA, Gray ML, Estépar RS.

Sci Rep. 2016 Oct 5;6:34468. doi: 10.1038/srep34468.

28.

Functions of the basal ganglia-paradox or no paradox?

Crossman AR, Obeso JA.

Mov Disord. 2016 Aug;31(8):1120-1. doi: 10.1002/mds.26745. No abstract available.

PMID:
27506637
29.

Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.

Singh A, Mewes K, Gross RE, DeLong MR, Obeso JA, Papa SM.

Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9629-34. doi: 10.1073/pnas.1606792113. Epub 2016 Aug 8.

30.

Hyperkinetic disorders and loss of synaptic downscaling.

Calabresi P, Pisani A, Rothwell J, Ghiglieri V, Obeso JA, Picconi B.

Nat Neurosci. 2016 Jun 28;19(7):868-75. doi: 10.1038/nn.4306. Review.

PMID:
27351172
31.

Parkinson's disease and thalamus: facts and fancy.

Blesa J, Trigo-Damas I, Obeso JA.

Lancet Neurol. 2016 Jun;15(7):e2. doi: 10.1016/S1474-4422(16)30048-5. Epub 2016 May 9. No abstract available.

PMID:
27302241
32.

The Movement Disorders journal 2016 and onward.

Obeso JA.

Mov Disord. 2016 Jan;31(1):1-2. doi: 10.1002/mds.26518. Epub 2016 Jan 9. No abstract available.

PMID:
26749243
33.

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Gasca-Salas C, Clavero P, García-García D, Obeso JA, Rodríguez-Oroz MC.

Hum Brain Mapp. 2016 Mar;37(3):968-77. doi: 10.1002/hbm.23080. Epub 2015 Dec 14.

PMID:
26663702
34.

Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease.

Hernández LF, Redgrave P, Obeso JA.

Front Neuroanat. 2015 Nov 17;9:146. doi: 10.3389/fnana.2015.00146. eCollection 2015.

35.

A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Jahanshahi M, Obeso I, Rothwell JC, Obeso JA.

Nat Rev Neurosci. 2015 Dec;16(12):719-32. doi: 10.1038/nrn4038. Epub 2015 Nov 4. Review.

PMID:
26530468
36.

Editorial: Parkinson's disease: cell vulnerability and disease progression.

Blesa J, Lanciego JL, Obeso JA.

Front Neuroanat. 2015 Sep 15;9:125. doi: 10.3389/fnana.2015.00125. eCollection 2015. No abstract available.

37.

Computer-Based Visualization System for the Study of Deep Brain Structures Involved in Parkinson's Disease.

Juanes JA, Ruisoto P, Obeso JA, Prats A, San-Molina J.

J Med Syst. 2015 Nov;39(11):151. doi: 10.1007/s10916-015-0348-6. Epub 2015 Sep 14.

PMID:
26370536
38.

Habitual behavior and dopamine cell vulnerability in Parkinson disease.

Hernández LF, Redgrave P, Obeso JA.

Front Neuroanat. 2015 Aug 6;9:99. doi: 10.3389/fnana.2015.00099. eCollection 2015. No abstract available. Erratum in: Front Neuroanat. 2015;9:146.

39.

NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients.

Mellone M, Stanic J, Hernandez LF, Iglesias E, Zianni E, Longhi A, Prigent A, Picconi B, Calabresi P, Hirsch EC, Obeso JA, Di Luca M, Gardoni F.

Front Cell Neurosci. 2015 Jul 6;9:245. doi: 10.3389/fncel.2015.00245. eCollection 2015.

40.

Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.

Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C, Peñuelas I, Obeso JA.

Neurobiol Dis. 2015 May;77:165-72. doi: 10.1016/j.nbd.2015.01.007. Epub 2015 Feb 12.

PMID:
25681534
41.

Letter to the editor: Parkinson's disease and early subthalamotomy.

Guridi J, Obeso JA.

J Neurosurg. 2015 Apr;122(4):980-1. doi: 10.3171/2014.8.JNS141799. Epub 2015 Feb 13. No abstract available.

PMID:
25679280
42.

The Movement Disorders Journal 2015 and onwards: Tradition changes, the challenges remain the same.

Obeso JA.

Mov Disord. 2015 Feb;30(2):167-8. doi: 10.1002/mds.26155. No abstract available.

PMID:
25648697
43.

Can levodopa-induced dyskinesias go beyond the motor circuit?

Rothwell JC, Obeso JA.

Brain. 2015 Feb;138(Pt 2):242-4. doi: 10.1093/brain/awu365. No abstract available.

PMID:
25627235
44.

The end of the term.

Olanow CW, Obeso JA.

Mov Disord. 2014 Dec;29(14):1703-4. doi: 10.1002/mds.26106. No abstract available.

PMID:
25487521
45.

Scientific perspectives.

Standaert DG, Olanow CW, Obeso JA.

Mov Disord. 2014 Sep;29(10):1230. doi: 10.1002/mds.26015. No abstract available.

PMID:
25209257
46.

Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.

Gasca-Salas C, Estanga A, Clavero P, Aguilar-Palacio I, González-Redondo R, Obeso JA, Rodríguez-Oroz MC.

J Parkinsons Dis. 2014;4(4):677-86. doi: 10.3233/JPD-140398.

PMID:
25208730
47.

Impact factor for 2013.

Olanow CW, Obeso JA.

Mov Disord. 2014 Aug;29(9):1091. doi: 10.1002/mds.26002. No abstract available.

PMID:
25137429
48.

The expanding universe of disorders of the basal ganglia.

Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ.

Lancet. 2014 Aug 9;384(9942):523-31. doi: 10.1016/S0140-6736(13)62418-6. Epub 2014 Jun 18. Review.

PMID:
24954674
49.

Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

González-Redondo R, García-García D, Clavero P, Gasca-Salas C, García-Eulate R, Zubieta JL, Arbizu J, Obeso JA, Rodríguez-Oroz MC.

Brain. 2014 Aug;137(Pt 8):2356-67. doi: 10.1093/brain/awu159. Epub 2014 Jun 20.

50.

Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.

Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O.

J Neurosci. 2014 Jun 11;34(24):8210-8. doi: 10.1523/JNEUROSCI.5456-13.2014. Erratum in: J Neurosci. 2015 Nov 25;35(47):15767.

Supplemental Content

Loading ...
Support Center